# PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE
> **ANDA214238** · Abbreviated New Drug Application (Generic) · Sponsor: QUAGEN · Approved 2020-10-08
## Drug
- **FDA Application Number:** ANDA214238
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE
- **Generic name:** PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE
- **Active ingredients:** CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE
- **Dosage form:** SYRUP
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** QUAGEN
- **Manufacturer:** QUAGEN PHARMACEUTICALS LLC
- **First approval:** 2020-10-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214238)
---
*MORVS · CC0 1.0*